Dudediligence.

Odyssey Therapeutics, Inc

ODTXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.9MMar ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$38.4MMar ’25−$38.3MMar ’26−$52.8MJun ’26